-
the possibility of renewal subject to satisfactory performance and funding availability. Applicants should have a Ph.D. degree, preferably in pluripotent stem cell biology, cellular reprogramming or bioinformatics
-
. Applicants should have a PhD in structural biology, biochemistry, or a related field. He/She will have a proven track record in using cryo-EM for protein structure determination. Experience in (membrane
-
years, with the possibility of renewal subject to satisfactory performance. Applicants should possess a Ph.D. degree, proven experience and good publication record in molecular biology. Experience in
-
cancer biology, immunology or related areas will be an advantage. The appointee will work on research projects related to cancer immunology and immunotherapy, with a focus on investigating T-cell-mediated
-
of renewal subject to satisfactory performance. Applicants should have a Ph.D. degree in a biological biomedical, or related field, with experience in molecular and cell biology. They should be organized, self
-
the research group. Requirements: Education and Expertise: Ph.D. in Pharmaceutical Sciences, Pharmacology, Biology, Molecular Biology, Biochemistry, Immunology, Bioengineering, Chemistry, Data Science or related
-
the possibility of renewal subject to satisfactory performance and funding availability. Applicants should possess a Ph.D. degree in Stem Cell Biology, Cancer Immunology, Genomics, Bioinformatics, or a related
-
, Polymer Science, Applied Chemistry, Chemical Engineering, Biomedical Engineering, Computer and Electrical Engineering, Biological Science or a related discipline. Proficiency in English, along with strong
-
, Chinese Medicine, Cancer Biology, Molecular Biology, Biochemistry, Biotechnology Research experience in animal studies, cell culture and molecular biology, preferably in herbal medicines and/or cancer
-
or related fields, and a good publication track record. Experience in multi-color flow cytometric analysis; cell-based immune assays; animal work; and laboratory-based translational research in cancer biology